Research and Markets: Allergic Rhinitis - Epidemiology Forecast to 2023

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/2hm68j/epicast_report) has announced the addition of the "EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023" report to their offering.

Allergic rhinitis is a chronic respiratory disease characterized by inflammation of the nasal cavity and affects people of all ages. The main symptoms of allergic rhinitis are sneezing, nasal itching, blocked or runny nose and sore throat (NHS, 2012; WHO, 2013). Research suggests that a combination of genetic factors such as family history of allergic rhinitis and environmental factors such as exposure to allergens, including smoke, dust, pollen, insects, molds, or animal dander, may increase the risk for developing allergic rhinitis (NHS, 2012; WHO, 2013). In the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan), the prevalence of self-reported allergic rhinitis ranges from 13.7% in men and 14.3% in women in the US to 35.1% in men and 39.3% in women in Japan (Bauchau and Durham, 2004; Konno et al., 2012; Nathan et al., 1997; Ozdoganoglu and Songu, 2012). According to the World Health Organization (WHO), an estimated 400 million people worldwide were affected with allergic rhinitis during 1996-2006 (WHO, 2007).

This report provides an overview of the risk factors, comorbidities, and the global and historical trends for allergic rhinitis in the 7MM. The report also includes a 10-year epidemiological forecast of the total prevalent cases of allergic rhinitis in these markets, segmented by sex and age (ages =18 years).

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Epidemiology

3.1 Disease Background

3.2 Risk Factors and Comorbidities

3.2.1 Family history of allergic rhinitis is a strong predictor for allergic rhinitis in children and adults

3.2.2 Exposure to allergens in the environment increases the risk for allergic rhinitis

3.2.3 Urban living elevates the risk of allergic rhinitis

3.2.4 People with allergic rhinitis suffer from several comorbidities

3.3 Global and Historical Trends

3.4 Forecast Methodology

3.5 Epidemiological Forecast of Allergic Rhinitis (2013-2023)

3.5.1 Total Prevalent Cases of Allergic Rhinitis

3.5.2 Age-Specific Total Prevalent Cases of Allergic Rhinitis

3.5.3 Sex-Specific Total Prevalent Cases of Allergic Rhinitis

3.5.4 Age-Standardized Total Prevalence of Allergic Rhinitis

3.5.5 Distribution of Total Prevalent Cases of Allergic Rhinitis by Severity

3.5.6 Distribution of Total Prevalent Cases of Allergic Rhinitis by Type

3.5.7 Allergic Rhinitis Total Prevalent Cases Sensitized to Specific Allergens

3.6 Discussion

3.6.1 Epidemiological Forecast Insight

3.6.2 Limitations of the Analysis

3.6.3 Strengths of the Analysis

4 Appendix

For more information visit http://www.researchandmarkets.com/research/2hm68j/epicast_report

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Respiratory

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Respiratory